PP

Peter Pete Smith

Race Oncology Ltd | Executive Director, Executive Chairman
Dr Smith has over 35 years of experience in the pharmaceutical and biotech industry, with a focus on therapeutics, especially oncology. He has been involved in projects at all stages from concept to phase III clinical studies. He was previously the CEO of private biotechnology company Myrio Therapeutics, and publicly listed Australian companies Alchemia and AMRAD. Prior to moving to Australia, Dr Smith co-founded and was CFO of Onyvax Ltd, a cancer immunotherapy company based in London. At the start of his career, he was a Pharmaceuticals Analyst with UBS and HSBC, being involved in transactions including LSE/NASDAQ initial public offerings, fundraisings, and mergers & acquisitions (M&A). He is also currently a Director of MycRx Inc. and Amala Therapeutics.

Company and Roles

Company
Title
Tenure
Since
RAC
Race Oncology Ltd
  • Executive Director
  • Executive Chairman
1yrs, 7mthJun 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAC
Race Oncology Ltd
30/06/24N/AN/A440,019N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAC
Race Oncology Ltd
01/12/23
Issued
440,019$0.850$374,016Issue of options